Raplam Pharmaceuticals Private Limited - Company Profile

It is a electrnoics private limited company based in Bangalore, Karnataka, India, established in 2020.
2020 Bangalore, Karnataka, India Struck Off
Last Updated:
Access Report
About Raplam Pharmaceuticals Private Limited

Raplam Pharmaceuticals Private Limited, a struck off private limited company, was established on 17 August 2020 in Bangalore, Karnataka, India. Engaging in repair services within the electrnoics sector, it holds CIN: U52609KA2020PTC137339. Registered under ROC Roc Bangalore. it is unlisted. It has an authorized capital of ₹1.00 M and a paid-up capital of ₹0.50 M.

Its leadership includes Kumar Ranjan (Director), Chikkaballapur Narasimaiah Mohan Kumar (Director), Talkadu Shankar Ganesh (Director). It is based at No.23/4, M E S Road Muthyalanagar, Jalahalli, Bangalore, Karnataka, 560013.

Company Details
  • Email
    **********
  • Telephone

    +91-XXXXXXXXXX

  • Website
    **********
  • Social Media
    **********
  • Apps
    **********

Company Details

  • CIN/LLPIN

    U52609KA2020PTC137339

  • Registration Number

    137339

  • Incorporation Date

    17 August 2020

  • Authorized Capital

    ₹1.00 M

  • Paid-Up Capital

    ₹0.50 M

  • ROC Code

    Roc Bangalore

  • Listing Status

    Unlisted

  • Company Status

    Struck Off

Key Metrics
  • Authorised Capital ₹ 1.00 M
  • Paid Up Capital ₹ 0.50 M
  • Company Age 5 Year, 5 Months
Company report

Raplam Pharmaceuticals Private Limited

Company Report FY 2025-2026

Comprehensive Company Insights

Explore comprehensive insights into Raplam Pharmaceuticals Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.

Access Report Banner Element
Who are the key members and board of directors at Raplam Pharmaceuticals Private Limited?
Current Directors
Name Designation Appointment Date Status
Kumar Ranjan Director 17 Aug 2020 Current
Chikkaballapur Narasimaiah Mohan Kumar Director 17 Aug 2020 Current
Talkadu Shankar Ganesh Director 17 Aug 2020 Current

Discover detailed profiles of directors and KMP - Unlock leadership insights today!

Financial Performance of Raplam Pharmaceuticals.

Enhance accessibility to Raplam Pharmaceuticals's financial data by unlocking access to both Standalone and Consolidated balance sheets, Profit & Loss Statements, Ratios, Related Party Transactions, and additional relevant information.

Raplam Pharmaceuticals revenue growth over time
Raplam Pharmaceuticals profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors
Emtek
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
Jan, 2021 Amount Post-IPO - Grab Valuation

investors
Hana Financial Group , GGV Capital
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
  • Key Matrics
  • Balance Sheet
  • Profit and Loss
  • Cash Flow
  • Ratios
Metrics
(FY 2023) YOY Growth
(FY 2022) (FY 2021) (FY 2020) (FY 2019)
Total Revenue
********
*******
*******
*******
*******
*******
Revenue from Operations
*******
*******
*******
*******
*******
*******
Total Assets
*******
*******
*******
*******
*******
*******
Profit or Loss
*******
*******
*******
*******
*******
*******
Net Worth
*******
*******
*******
*******
*******
*******
EBITDA
*******
*******
*******
*******
*******
*******

Discover detailed financial data and - Unlock financial today!

What is the Ownership and Shareholding Structure of Raplam Pharmaceuticals?

Unlock access to Raplam Pharmaceuticals's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.

Shareholding Pattern (FY 2024)
shareholding
  • Promoters: 92.83%
  • Public: 4.10%
  • Others: 3.07%
Shareholding Pattern over the Year
FY (2024) FY (2023) FY (2022) FY (2021) FY (2020)
Promoters 92.83 94.62 94.55 94.55 94.55
Public 4.10 3.89 3.95 3.96 3.98
Others 3.07 1.49 1.50 1.49 1.47

Reveal ownership structures and financial performance - Get instant access now!

How Many Employees Work at Raplam Pharmaceuticals?

Raplam Pharmaceuticals has a workforce of 0 employees as of Apr 05, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.

Employee Date Number of Employees
2020 78,000
2021 80,500
2022 83,200
2023 86,000
2024 89,500
2025 92,000
Deals i
Graph showing company valuation over time

Gain comprehensive insights into the Deals and Valuation data of Raplam Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Raplam Pharmaceuticals's trajectory.

Rating
Graph displaying rating trends over time

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts
Alert Indicator

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Explore deal ratings and alerts - Get instant access now!

Latest Updates, News, and FAQs on Raplam Pharmaceuticals
Recent Activity within the Organization
  • Director Appointment

    The activity Kumar Ranjan was appointed as a Director was appointed as a Director on 17 Aug 2020 & has been associated with this company since 5 years 5 months . was completed.

  • Director Appointment

    The activity Chikkaballapur Narasimaiah Mohan Kumar was appointed as a Director was appointed as a Director on 17 Aug 2020 & has been associated with this company since 5 years 5 months . was completed.

  • Director Appointment

    Talkadu Shankar Ganesh was appointed as a Director was appointed as a Director on 17 Aug 2020 & has been associated with this company since 5 years 5 months . was recorded as a recent event.

  • Company Incorporation

    The activity Raplam Pharmaceuticals Private Limited was registered on 17 Aug 2020 with Roc Bangalore & aged 5 years 5 months as per MCA records. was completed.

Explore recent activity and updates - View Recent Activity

Frequently Asked Questions
What is the CIN of Raplam Pharmaceuticals Private Limited?

The CIN of Raplam Pharmaceuticals Private Limited is U52609KA2020PTC137339.

Where is Raplam Pharmaceuticals Private Limited headquartered?

Raplam Pharmaceuticals Private Limited is headquartered at No.23/4, M E S Road Muthyalanagar, Jalahalli, Bangalore, Karnataka, 560013.

When was Raplam Pharmaceuticals Private Limited incorporated?

Raplam Pharmaceuticals Private Limited was incorporated on 17 August 2020.

Who are the current directors of Raplam Pharmaceuticals Private Limited?

The current directors of Raplam Pharmaceuticals Private Limited are

What is the primary industry of Raplam Pharmaceuticals Private Limited?

The primary industry of Raplam Pharmaceuticals Private Limited is Electrnoics.

Is Raplam Pharmaceuticals Private Limited a listed company?

Raplam Pharmaceuticals Private Limited is unlisted.

What is the capital structure of Raplam Pharmaceuticals Private Limited?

The authorized capital of Raplam Pharmaceuticals Private Limited is ₹1.00 M, and the paid-up capital is ₹0.50 M.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available